{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:58Z","timestamp":1789560778063,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100724","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:13:07Z","timestamp":1781698387000},"page":"100724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach"],"prefix":"10.1016","volume":"24","author":[{"given":"Oukhdouch","family":"Anass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadir","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"El mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jebhi","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinbi","family":"Basma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sellami","family":"Souad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rais","family":"Hanane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgeb.2026.100724_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96935-y","article-title":"Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme","volume":"11","author":"Mesic","year":"2021","journal-title":"Sci Rep"},{"issue":"12 Suppl 2","key":"10.1016\/j.jgeb.2026.100724_bb0010","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.jgeb.2026.100724_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0020","article-title":"EGFR gene amplification in IDH-wildtype glioblastomas: an integrative bioinformatic and histopathological analysis using immunohistochemistry and fluorescence in situ hybridization","volume":"16","author":"Oukhdouch","year":"2025","journal-title":"Discov Oncol"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0092-8674(03)01075-4","article-title":"Principles of tumor suppression","volume":"116","author":"Sherr","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jgeb.2026.100724_bb0035","doi-asserted-by":"crossref","unstructured":"Jhaveri K, Burris HA, Yap TA, et al. The evolution of cyclin dependent kinase inhibitors in the treatment of cancer. Expert Rev Anticancer Ther 2021;21(10):1105\u20131124. doi:https:\/\/doi.org\/10.1080\/14737140.2021.1944109.","DOI":"10.1080\/14737140.2021.1944109"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jgeb.2026.100724_bb0050","doi-asserted-by":"crossref","unstructured":"Agosti E, Zeppieri M, De Maria L, et al. Glioblastoma immunotherapy: a systematic review of the present strategies and prospects for advancements. Int J Mol Sci 2023;24(20):15037. doi:https:\/\/doi.org\/10.3390\/ijms242015037.","DOI":"10.3390\/ijms242015037"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jphs.2021.09.002","article-title":"Effect of Piper cubeba total extract and isolated lignans on head and neck cancer cell lines and normal fibroblasts","volume":"148","author":"Gusson-Zanetoni","year":"2022","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jgeb.2026.100724_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1048520","article-title":"Cubeb (Piper cubeba L.f.): a comprehensive review of its botany, phytochemistry, traditional uses, and pharmacological properties","volume":"9","author":"Drissi","year":"2022","journal-title":"Front Nutr"},{"issue":"06","key":"10.1016\/j.jgeb.2026.100724_bb0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1055\/s-0042-101761","article-title":"(\u2212)-Hinokinin induces G2\/M arrest and contributes to the Antiproliferative effects of doxorubicin in breast Cancer cells","volume":"82","author":"Cunha","year":"2016","journal-title":"Planta Med"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/open.201700182","article-title":"Medicinal attributes of Lignans extracted from piper Cubeba: current developments","volume":"7","author":"Godoy de Lima","year":"2018","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.jgeb.2026.100724_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"issue":"37","key":"10.1016\/j.jgeb.2026.100724_bb0080","doi-asserted-by":"crossref","first-page":"17374","DOI":"10.1039\/D5SC05395A","article-title":"Decoding the limits of deep learning in molecular docking for drug discovery","volume":"16","year":"2025","journal-title":"Chem Sci"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100724_bb0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100724_bb0090","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis","volume":"184","author":"Mathewson","year":"2021","journal-title":"Cell"},{"issue":"6592","key":"10.1016\/j.jgeb.2026.100724_bb0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.abi6378","article-title":"Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress","volume":"376","author":"Larsen","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bmcl.2016.11.081","article-title":"In vivo and in silico anti-inflammatory mechanism of action of the semisynthetic (\u2212)-cubebin derivatives (\u2212)-hinokinin and (\u2212)-O-benzylcubebin","volume":"27","author":"Lima","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100724_bb0105","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.3390\/molecules190914862","article-title":"Hinokinin, an emerging bioactive lignan","volume":"19","author":"Marcotullio","year":"2014","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.jgeb.2026.100724_bb0110","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/np500093u","article-title":"Chemopreventive effects of (\u2212)-Hinokinin against 1,2-dimethylhydrazine-induced genotoxicity and preneoplastic lesions in rat Colon","volume":"77","author":"Barbosa","year":"2014","journal-title":"J Nat Prod"},{"issue":"40","key":"10.1016\/j.jgeb.2026.100724_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039205","article-title":"Construction and validation of cell cycle-related prognostic genetic model for glioblastoma","volume":"103","author":"Zhou","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100724_bb0120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djm011","article-title":"Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma","volume":"99","author":"Ng","year":"2007","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-023-03090-7","article-title":"Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics","volume":"23","author":"Tabnak","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jgeb.2026.100724_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107499","article-title":"Clinical and molecular immune characterization of ERBB2 in glioma","volume":"94","author":"Mei","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100724_bb0135","article-title":"High cytoplasmic FOXO1 and pFOXO1 expression in Astrocytomas are associated with worse surgical outcome","volume":"8","author":"Chen","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0140","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/2211-5463.13547","article-title":"The FOXO1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells","volume":"13","author":"Flores","year":"2023","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jgeb.2026.100724_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146325","article-title":"A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma","volume":"822","author":"Liu","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.jgeb.2026.100724_bb0150","doi-asserted-by":"crossref","unstructured":"Luo L, Zhang XY, Zhen YW, et al. Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. Front Immunol 2022;13:1058036. doi:https:\/\/doi.org\/10.3389\/fimmu.2022.1058036.","DOI":"10.3389\/fimmu.2022.1058036"},{"issue":"22","key":"10.1016\/j.jgeb.2026.100724_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216396","article-title":"Identification of CDK1, PBK, and CHEK1 as an oncogenic signature in glioblastoma: a bioinformatics approach to repurpose Dapagliflozin as a therapeutic agent","volume":"24","author":"Chinyama","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3171\/2010.3.PEDS10120","article-title":"Aurora kinase a as a rational target for therapy in glioblastoma","volume":"6","author":"Barton","year":"2010","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100724_bb0165","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100724_bb0170","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/biology12121511","article-title":"Expanding roles of the E2F-RB-p53 pathway in tumor suppression","volume":"12","author":"Zhou","year":"2023","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100724_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000863","article-title":"Cdk2 is required for p53-independent G2\/M checkpoint control","volume":"6","author":"Chung","year":"2010","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100724_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jgeb.2026.100724_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02353-3","article-title":"Aurora kinases signaling in cancer: from molecular perception to targeted therapies","volume":"24","author":"Vats","year":"2025","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100724_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.36401\/JIPO-24-23","article-title":"A comprehensive exploration of agents targeting tumor microenvironment: challenges and future perspectives","volume":"7","author":"Lopes","year":"2024","journal-title":"J Immunother Precis Oncol"},{"key":"10.1016\/j.jgeb.2026.100724_bb0200","doi-asserted-by":"crossref","unstructured":"Liu J, Deng Y, Pu Z, et al. The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma. JCI Insight 10(5):e173700. doi:https:\/\/doi.org\/10.1172\/jci.insight.173700.","DOI":"10.1172\/jci.insight.173700"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100724_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes anti-tumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100724_bb0210","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.jgeb.2026.100724_bb0220","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100724_bb0225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrc2964","article-title":"Shared and separate functions of polo-like kinases and aurora kinases in cancer","volume":"10","author":"Lens","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jgeb.2026.100724_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13073-018-0567-9","article-title":"Single-cell transcriptome analysis of lineage diversity in high-grade glioma","volume":"10","author":"Yuan","year":"2018","journal-title":"Genome Med"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100724_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrm3819","article-title":"Polo-like kinases: structural variations lead to multiple functions","volume":"15","author":"Zitouni","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgeb.2026.100724_bb0245","article-title":"Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking","volume":"14","author":"He","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100724_bb0250","first-page":"127","article-title":"3D-QSAR studies, molecular docking, molecular dynamic simulation, and ADMET proprieties of novel pteridinone derivatives as PLK1 inhibitors for the treatment of prostate cancer","volume":"13","author":"Er-rajy","year":"2023","journal-title":"Life (Basel)"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:47Z","timestamp":1789560047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26000685"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100724","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100724"}}